Agenus Inc.
NASDAQ:AGEN
2.83 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Agenus Inc. |
Symbool | AGEN |
Munteenheid | USD |
Prijs | 2.83 |
Beurswaarde | 66,388,687 |
Dividendpercentage | 0% |
52-weken bereik | 2.5 - 19.69 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Garo H. Armen Ph.D. |
Website | https://www.agenusbio.com |
An error occurred while fetching data.
Over Agenus Inc.
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs comprising Prophage vaccine candidate; and QS-21 Stimulon
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)